Inmune Bio Stock Math Transform Inverse Tangent Over Price Movement

INMB Stock  USD 11.70  0.41  3.63%   
INmune Bio math transform tool provides the execution environment for running the Inverse Tangent Over Price Movement transformation and other technical functions against INmune Bio. INmune Bio value trend is the prevailing direction of the price over some defined period of time. The concept of trend is an important idea in technical analysis, including the analysis of math transform indicators. As with most other technical indicators, the Inverse Tangent Over Price Movement transformation function is designed to identify and follow existing trends. Analysts that use price transformation techniques rely on the belief that biggest profits from investing in INmune Bio can be made when INmune Bio shifts in price trends from positive to negative or vice versa.

Transformation
The output start index for this execution was zero with a total number of output elements of sixty-one. INmune Bio Inverse Tangent Over Price Movement function is an inverse trigonometric method to describe INmune Bio price patterns.

INmune Bio Technical Analysis Modules

Most technical analysis of INmune Bio help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for INmune from various momentum indicators to cycle indicators. When you analyze INmune charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About INmune Bio Predictive Technical Analysis

Predictive technical analysis modules help investors to analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of INmune Bio. We use our internally-developed statistical techniques to arrive at the intrinsic value of INmune Bio based on widely used predictive technical indicators. In general, we focus on analyzing INmune Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build INmune Bio's daily price indicators and compare them against related drivers, such as math transform and various other types of predictive indicators. Using this methodology combined with a more conventional technical analysis and fundamental analysis, we attempt to find the most accurate representation of INmune Bio's intrinsic value. In addition to deriving basic predictive indicators for INmune Bio, we also check how macroeconomic factors affect INmune Bio price patterns. Please read more on our technical analysis page or use our predictive modules below to complement your research.
 2021 2022 2023 2024 (projected)
Graham Number14.5110.988.925.75
Receivables Turnover0.03290.04420.06350.0603
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of INmune Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
5.6111.2816.95
Details
Intrinsic
Valuation
LowRealHigh
7.7113.3819.05
Details
Naive
Forecast
LowNextHigh
6.8312.5018.17
Details
3 Analysts
Consensus
LowTargetHigh
15.7717.3319.24
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as INmune Bio. Your research has to be compared to or analyzed against INmune Bio's peers to derive any actionable benefits. When done correctly, INmune Bio's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in INmune Bio.

Be your own money manager

As an individual investor, you need to find a reliable way to track all your investment portfolios' performance accurately. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing you full analytical transparency into your positions, our tools can tell you how much better you can do without increasing your risk or reducing expected return.

Generate Optimal Portfolios

Align your risk and return expectations

Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether INmune Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of INmune Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inmune Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inmune Bio Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in INmune Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population.
For information on how to trade INmune Stock refer to our How to Trade INmune Stock guide.
You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for INmune Stock analysis

When running INmune Bio's price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Global Correlations
Find global opportunities by holding instruments from different markets
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Is INmune Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of INmune Bio. If investors know INmune will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about INmune Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(1.67)
Revenue Per Share
0.009
Quarterly Revenue Growth
(0.71)
Return On Assets
(0.27)
Return On Equity
(0.61)
The market value of INmune Bio is measured differently than its book value, which is the value of INmune that is recorded on the company's balance sheet. Investors also form their own opinion of INmune Bio's value that differs from its market value or its book value, called intrinsic value, which is INmune Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because INmune Bio's market value can be influenced by many factors that don't directly affect INmune Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between INmune Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if INmune Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, INmune Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.